177 related articles for article (PubMed ID: 23580180)
21. Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.
Yonemori K; Tsuta K; Ando M; Hirakawa A; Hatanaka Y; Matsuno Y; Chuman H; Yamazaki N; Fujiwara Y; Hasegawa T
Ann Surg Oncol; 2011 Oct; 18(10):2841-50. PubMed ID: 21409488
[TBL] [Abstract][Full Text] [Related]
22. Effect of c-Met and CD44v6 Expression in Resistance to Chemotherapy in Esophageal Squamous Cell Carcinoma.
Hara T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Matsuura N; Mori M; Doki Y
Ann Surg Oncol; 2019 Mar; 26(3):899-906. PubMed ID: 30610559
[TBL] [Abstract][Full Text] [Related]
23. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
[TBL] [Abstract][Full Text] [Related]
24. Human epidermal growth factor receptor 2, epidermal growth factor receptor, and c-MET overexpression and survival in biliary tract cancer: A meta-analysis.
Zhou W; Jiang C; Zhan N; Lv X; Fan L; Ninu M
J Cancer Res Ther; 2018; 14(Supplement):S28-S35. PubMed ID: 29578146
[TBL] [Abstract][Full Text] [Related]
25. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
Chen HM; Tsai CH; Hung WC
Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
[TBL] [Abstract][Full Text] [Related]
26. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness.
Dhakal HP; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Bassarova A; Holm R; Giercksky KE; Nesland JM
Histopathology; 2012 Sep; 61(3):350-64. PubMed ID: 22690749
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Hodgkin lymphoma.
Dimtsas GS; Georgiadi EC; Karakitsos P; Vassilakopoulos TP; Thymara I; Korkolopoulou P; Patsouris E; Kittas C; Doussis-Anagnostopoulou IA
Leuk Lymphoma; 2014 Mar; 55(3):558-64. PubMed ID: 23772669
[TBL] [Abstract][Full Text] [Related]
28. Inverse correlation of phospho-KDR/Flk-1 expression and stage of colorectal cancer: implication of the significance of neoangiogenesis in activated VEGFR-2 expressing early stage colorectal adenocarcinomas.
Lin YF; Chang CC; Lin SH; Yeh CM; Su TC; Wu PR; Yeh KT; Jiang MC; Chen PY; Hsu HT
Pol J Pathol; 2014 Oct; 65(3):194-201. PubMed ID: 25372416
[TBL] [Abstract][Full Text] [Related]
29. Expression of GLI1 correlates with expression of lymphangiogenesis proteins, vascular endothelial growth factor C and vascular endothelial growth factor receptor 3, in colorectal cancer.
Hong KD; Lee Y; Kim BH; Lee SI; Moon HY
Am Surg; 2013 Feb; 79(2):198-204. PubMed ID: 23336661
[TBL] [Abstract][Full Text] [Related]
30. [Expression of molecular markers detected by immunohistochemistry and risk of lymph node metastasis in stage T1 and T2 colorecrectal cancers].
Wang FL; Wan DS; Lu ZH; Fang YJ; Li LR; Chen G; Wu XJ; Ding PR; Kong LH; Lin JZ; Pan ZZ
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):277-81. PubMed ID: 23985256
[TBL] [Abstract][Full Text] [Related]
31. Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
Kocael A; Vatankulu B; Şimşek O; Cengiz M; Kemik A; Kocael P; Halaç M; Sönmezoğlu K; Ulualp K
Tumour Biol; 2016 Mar; 37(3):3871-7. PubMed ID: 26476536
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
[TBL] [Abstract][Full Text] [Related]
33. CD44V6 expression in human colorectal carcinoma.
Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS
Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor receptor-3 activity is modulated by its association with caveolin-1 on endothelial membrane.
Galvagni F; Anselmi F; Salameh A; Orlandini M; Rocchigiani M; Oliviero S
Biochemistry; 2007 Apr; 46(13):3998-4005. PubMed ID: 17348685
[TBL] [Abstract][Full Text] [Related]
35. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
36. Caveolin-1 Inhibits Proliferation, Migration, and Invasion of Human Colorectal Cancer Cells by Suppressing Phosphorylation of Epidermal Growth Factor Receptor.
Yang J; Zhu T; Zhao R; Gao D; Cui Y; Wang K; Guo Y
Med Sci Monit; 2018 Jan; 24():332-341. PubMed ID: 29339715
[TBL] [Abstract][Full Text] [Related]
37. Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival.
Jia JB; Zhuang PY; Sun HC; Zhang JB; Zhang W; Zhu XD; Xiong YQ; Xu HX; Tang ZY
J Cancer Res Clin Oncol; 2009 Jun; 135(6):847-54. PubMed ID: 19066962
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.
Šelemetjev S; Bartolome A; Išić Denčić T; Đorić I; Paunović I; Tatić S; Cvejić D
Int J Exp Pathol; 2018 Apr; 99(2):87-94. PubMed ID: 29665129
[TBL] [Abstract][Full Text] [Related]
39. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.
Nordby Y; Andersen S; Richardsen E; Ness N; Al-Saad S; Melbø-Jørgensen C; Patel HR; Dønnem T; Busund LT; Bremnes RM
Prostate; 2015 Nov; 75(15):1682-93. PubMed ID: 26268996
[TBL] [Abstract][Full Text] [Related]
40. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
